| Symbol | FENC |
|---|---|
| Name | FENNEC PHARMACEUTICALS INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Address | 68 TW ALEXANDER DRIVE,PO BOX 13628, RESEARCH TRIANGLE PARK, North Carolina, 27709, United States |
| Telephone | +1 919 636-4530 |
| Fax | — |
| — | |
| Website | https://www.fennecpharma.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001211583 |
| Description | Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its lead product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children. Additional info from NASDAQ: |
Raykov Rosty 🟡 adjusted position in 7.0K shares (1 derivative) of FENNEC PHARMACEUTICALS INC. (FENC) at $9.62 Transaction Date: May 31, 2026 | Filing ID: 000015
Read more📋 ROSTISLAV RAYKOV (Director) plans to sell 10K shares of FENNEC PHARMACEUTICALS INC. (at $9.62 each, total $94K) Filed: Jun 01, 2026 | ID: 005361
Read moreEvans Terry L 🟢 acquired 168 shares of FENNEC PHARMACEUTICALS INC. (FENC) Transaction Date: May 31, 2026 | Filing ID: 000006
Read moreSayad Pierre Sargis 🟢 acquired 168 shares of FENNEC PHARMACEUTICALS INC. (FENC) Transaction Date: May 31, 2026 | Filing ID: 000006
Read moreHackman Jeffrey S. 🟢 acquired 1.2K shares of FENNEC PHARMACEUTICALS INC. (FENC) Transaction Date: May 31, 2026 | Filing ID: 000008
Read moreAndrade Robert 🟢 acquired 1.7K shares of FENNEC PHARMACEUTICALS INC. (FENC) Transaction Date: May 31, 2026 | Filing ID: 000022
Read moreFennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting
Read more(99% Neutral) FENNEC PHARMACEUTICALS INC. (FENC) Announces Regulatory Update
Read moreFennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Read moreNew Form SCHEDULE 13G/A - FENNEC PHARMACEUTICALS INC. <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0001604867-26-000010 <b>Size:</b> 76 KB
Read more